Journal Article

Determination of Group A Streptococcal Anti-M Type-Specific Antibody in Sera of Rheumatic Fever Patients after 45 Years

James F. Bencivenga, Dwight R. Johnson and Edward L. Kaplan

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 49, issue 8, pages 1237-1239
Published in print October 2009 | ISSN: 1058-4838
Published online October 2009 | e-ISSN: 1537-6591 | DOI: https://dx.doi.org/10.1086/605673
Determination of Group A Streptococcal Anti-M Type-Specific Antibody in Sera of Rheumatic Fever Patients after 45 Years

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Group A streptococcal M type-specific protective antibodies—especially their persistence in humans—are incompletely understood. Such information is essential for understanding the epidemiology and pathogenesis of these infections and their sequelae and is equally crucial for producing a group A streptococcal vaccine. We studied 2 adults for type-specific antibody 45 years after they experienced documented rheumatic fever.

Journal Article.  1915 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.